Am. J. Respir. Crit. Care Med., Vol 153, No. 2, Feb 1996, 650-655.
IgG subclass deficiencies associated with bronchiectasis
J De Gracia, MJ Rodrigo, F Morell, M Vendrell, M Miravitlles, MJ Cruz, R Codina and JM Bofill
Servei de Pneumologia, Hospital General Universitari Vall d'Hebron, Barcelona, Spain.
Only a small number of patients with IgG subclass deficiencies (IgGSD) have
been observed to have bronchiectasis. Moreover, in the series of patients
with bronchiectasis, IgGSD have not been found at any frequency, and the
etiology of bronchiectasis remains unclear in 29 to 49% of cases. Serum
concentrations of total IgG, IgA, and IgG subclasses as well as pulmonary
function were measured in 65 patients (aged: 10 to 74 yr) with
bronchiectasis of unknown etiology. An ELISA test was performed to quantify
subclasses 1 through 4 using subclass- specific antihuman monoclonal
antibodies. IgG subclass estimation in a healthy population with
age-stratified normal ranges was derived from 100 adults, 37 children aged
between 10 and 12 yr, and 27 adolescents aged between 13 and 16 yr. Serum
concentrations of specific IgG antibodies to Haemophilus influenzae type b
capsular polysaccharide (Hib-PRP) were also assayed by an ELISA test in 19
of the patients (10 with IgGSD and nine with non-IgGSD) and in 58 healthy
individuals before and 3 wk after immunization with Hib-PRP conjugated to
meningococcal outer membrane protein complex (OMPC). Thirty-one patients
(48%) had low serum concentrations of one or more IgG subclasses (19 IgG2
deficiencies, 2 IgG3 deficiencies, 3 IgG4 deficiencies, and 7 combined
subclass deficiencies). All patients showed increased levels of total IgG,
IgG1, and IgA, but this rise was significantly higher in patients without
IgGSD. Patients with IgGSD showed impaired antibody response to Hib-PRP
compared with patients with non-IgGSD and the control group. IgGSD,
particularly IgG2 deficiency, are not an unusual cause of bronchiectasis.
Therefore, serum levels of IgG subclasses must be assayed whenever other
causes of bronchiectasis have been ruled out.
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Rosen
Chronic Cough Due to Bronchiectasis: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
January 1, 2006;
129(1_suppl):
122S - 131S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Twigg III
Humoral Immune Defense (Antibodies): Recent Advances
Proceedings of the ATS,
December 1, 2005;
2(5):
417 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miravitlles, M. Vendrell, and J. de Gracia
Antibody deficiency in bronchiectasis
Eur. Respir. J.,
July 1, 2005;
26(1):
178 - 180.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vendrell, J. de Gracia, M.-J. Rodrigo, M.-J. Cruz, A. Alvarez, M. Garcia, and M. Miravitlles
Antibody Production Deficiency With Normal IgG Levels in Bronchiectasis of Unknown Etiology
Chest,
January 1, 2005;
127(1):
197 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Haciibrahimoglu, M. Fazlioglu, A. Olcmen, A. Gurses, and M. A. Bedirhan
Surgical management of childhood bronchiectasis due to infectious disease
J. Thorac. Cardiovasc. Surg.,
May 1, 2004;
127(5):
1361 - 1365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Schauer, F. Stemberg, C. H. L. Rieger, W. Buttner, M. Borte, S. Schubert, H. Mollers, F. Riedel, U. Herz, H. Renz, et al.
Levels of Antibodies Specific to Tetanus Toxoid, Haemophilus influenzae Type b, and Pneumococcal Capsular Polysaccharide in Healthy Children and Adults
Clin. Vaccine Immunol.,
March 1, 2003;
10(2):
202 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Barker
Bronchiectasis
N. Engl. J. Med.,
May 2, 2002;
346(18):
1383 - 1393.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Qvarfordt, G C Riise, B A Andersson, and S Larsson
IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations
Thorax,
June 1, 2001;
56(6):
445 - 449.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. C. PASTEUR, S. M. HELLIWELL, S. J. HOUGHTON, S. C. WEBB, J. E. FOWERAKER, R. A. COULDEN, C. D. FLOWER, D. BILTON, and M. T. KEOGAN
An Investigation into Causative Factors in Patients with Bronchiectasis
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1277 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. RODRIGO, M. VENDRELL, M.-J. CRUZ, M. MIRAVITLLES, C. PASCUAL, F. MORELL, and J. DE GRACIA
Utility of the Antibody Response to a Conjugated Haemophilus influenzae Type B Vaccine for Diagnosis of Primary Humoral Immunodeficiency
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1462 - 1465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miravitlles, J. de Gracia, M.-J. Rodrigo, M.-J. Cruz, M. Vendrell, R. Vidal, and F. Morell
Specific Antibody Response Against the 23-Valent Pneumococcal Vaccine in Patients With {alpha}1-Antitrypsin Deficiency With and Without Bronchiectasis
Chest,
October 1, 1999;
116(4):
946 - 952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S L Hill, J L Mitchell, D Burnett, and R A Stockley
IgG subclasses in the serum and sputum from patients with bronchiectasis
Thorax,
June 1, 1998;
53(6):
463 - 468.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|